EPTIFIBATIDA ROMPHARM 0.75mg/ml solution for infusion
eptifibatide Indicated for: prevention of atherothrombotic events
letter E · page 34
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eptifibatide Indicated for: prevention of atherothrombotic events
eculizumab Indicated for: complement-mediated disorders
combinations Indicated for: various therapeutic indications
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
cyclosporine Indicated for: immunosuppression
cyclosporine Indicated for: immunosuppression
cyclosporine Indicated for: immunosuppression
cyclosporine Indicated for: immunosuppression
docosanol Indicated for: herpes virus infections
D06BB11 Dermatologicals | Chemotherapeutics for topical use | Antivirals
cetuximab Indicated for: colorectal cancer; head and neck cancer
cetuximab Indicated for: colorectal cancer; head and neck cancer
nifuroxazide Indicated for: bacterial infections
erdosteine Indicated for: respiratory disorders with viscous secretions
R05CB15 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
erdosteine Indicated for: respiratory disorders with viscous secretions
R05CB15 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
erdosteine Indicated for: respiratory disorders with viscous secretions
R05CB15 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics